Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Comprehensive Molecular Profiling and Deep Clinical Annotation of Electronic Health Records in Participants Diagnosed With or at Risk of Developing Cancer (ASAP Study)

NCT05142033 is registered in ClinicalTrials.gov with Avera McKennan Hospital & University Health Center as lead sponsor.

NCT NCT05142033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Comprehensive Molecular Profiling and Deep Clinical Annotation of Electronic Health Records in Participants Diagnosed With or at Risk of Developing Cancer (ASAP Study)
Lead sponsor
Avera McKennan Hospital & University Health Center
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2021
Completion date
December 31, 2026
Enrollment
25,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer, cancer diagnosis, cns cancer, colon cancer, early detection of cancer, endometrial cancer, gi cancer, gynecologic cancer, hematologic cancer, lung cancer, ovarian cancer